Lanzamiento Enero 2027

Ensayo controlado aleatorizado2023

Longitudinal Changes and Predictive Value of Choroidal Thickness for Myopia Control after Repeated Low-Level Red-Light Therapy

Xiong R, Zhu Z, Jiang Y, Wang W, Zhang J, Chen Y, Bulloch G, Yuan Y, Zhang S, Xuan M, Zeng J, He M

Ophthalmology · 117 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Gobierno
National Natural Science Foundation of China
Subvenciones
National Natural Science Foundation of China (81271037); National Natural Science Foundation of China (81420108008)

Según 1 financiador declarado.

Publicación

Publicado
2022-10-11 · Ophthalmology · vol. 130 · número 3 · págs. 286–296
Editorial
Elsevier BV
Citado
155 citas · más que el 100% de estudios similares · 17.6× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
39 trabajos
Acceso
Acceso abierto (revista híbrida) · CC-BY-NC-ND
Áreas de investigación
Ophthalmology and Visual Impairment Studies · Retinal Diseases and Treatments · Retinopathy of Prematurity Studies
Palabras clave
Medicine, Ophthalmology, Predictive value, Longitudinal study, Optometry, Value (mathematics), Internal medicine
MeSH
choroid, humans, myopia, tomography, optical coherence, refraction, ocular, phototherapy, visual acuity, child, axial length, eye

12 autores

  • Ruilin Xiong🇨🇳Sun Yat-sen University
  • Zhuoting Zhu🇨🇳🇦🇺Sun Yat-sen University; The University of Melbourne; Centre for Eye Research Australia
  • Yu Jiang🇨🇳Sun Yat-sen University
  • Wei Wang🇨🇳Sun Yat-sen University
  • Jian Zhang🇨🇳Sun Yat-sen University
  • Yanping Chen🇨🇳Sun Yat-sen University
  • Gabriella Bulloch🇦🇺Centre for Eye Research Australia
  • Yixiong Yuan🇨🇳Sun Yat-sen University
  • Shiran Zhang🇨🇳Sun Yat-sen University
  • Meng Xuan🇨🇳Sun Yat-sen University
  • Junwen Zeng🇨🇳Sun Yat-sen University
  • Mingguang He🇨🇳🇦🇺 · autor de correspondenciaSun Yat-sen University; The University of Melbourne; Centre for Eye Research Australia

Resumen

El texto original del estudio, en el idioma en que se publicó.

Purpose

To evaluate longitudinal changes in macular choroidal thickness (mCT) in myopic children treated for 1 year with repeated low-level red-light (RLRL) therapy and their predictive value for treatment efficacy on myopia control.

Design

A secondary analysis of data from a multicenter, randomized controlled trial (RCT; NCT04073238).

Participants

Myopic children aged 8-13 years who participated in the RCT at 2 of 5 sites where mCT measurements were available.

Methods

Repeated low-level red-light therapy was delivered using a home-use desktop light device that emitted red-light at 650 nm. Choroidal thickness was measured by SS-OCT at baseline and 1-, 3-, 6-, and 12-month follow-ups. Visual acuity, axial length (AL), cycloplegic spherical equivalent refraction (SER), and treatment compliance were measured.

Main outcome measures

Changes in mCT at 1, 3, 6, and 12 months relative to baseline, and their associations with myopia control.

Results

A total of 120 children were included in the analysis (RLRL group: n = 60; single-vision spectacle [SVS] group: n = 60). Baseline characteristics were well balanced between the 2 groups. In the RLRL group, changes in mCT from baseline remained positive over 1 year, with a maximal increase of 14.755 μm at 1 month and gradually decreasing from 5.286 μm at 3 months to 1.543 μm at 6 months, finally reaching 9.089 μm at 12 months. In the SVS group, mCT thinning was observed, with changes from baseline of -1.111, -8.212, -10.190, and -10.407 μm at 1, 3, 6, and 12 months, respectively. Satisfactory myopia control was defined as annual progression rates of less than 0, 0.05, or 0.10 mm for AL and less than 0, 0.25, or 0.50 diopters for SER. Models that included mCT changes at 3 months alone had acceptable predictive discrimination of satisfactory myopia control over 12 months, with areas under the curve of 0.710-0.786. The predictive performance of the models did not significantly improve after adding age, gender, and baseline AL or SER.

Conclusions

This analysis from a multicenter RCT found RLRL induced sustained choroidal thickening over the full course of treatment. Macular choroidal thickness changes at 3 months alone can predict 12-month myopia control efficacy with reasonable accuracy.

Financial disclosure(s)

Proprietary or commercial disclosure may be found after the references.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY-NC-ND).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.